Ex vivo and in vitro effect of human immunodeficiency virus protease inhibitors on neutrophil apoptosis.
暂无分享,去创建一个
G. d’Ettorre | V. Vullo | M. Lichtner | C. Mastroianni | G. Russo | A. Massetti | F. Mengoni | C. D'Agostino | G. Forcina | M. Marzi
[1] J M Andrieu,et al. HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanism. , 2000, Blood.
[2] E. Acosta,et al. Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] A. Badley,et al. Decreased HIV-associated T cell apoptosis by HIV protease inhibitors. , 2000, AIDS research and human retroviruses.
[4] R. Grant,et al. Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. , 2000, The Journal of infectious diseases.
[5] F. Chiarotti,et al. Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] Pugliese,et al. Highly active anti‐retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV‐infected patients , 1999, Clinical and experimental immunology.
[7] M. Reitz,et al. HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells. , 1999, Journal of human virology.
[8] N. Young,et al. Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo. , 1999, Blood.
[9] A. Khwaja,et al. Caspase-mediated proteolysis and activation of protein kinase Cdelta plays a central role in neutrophil apoptosis. , 1999, Blood.
[10] G. d’Ettorre,et al. Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients. , 1999, AIDS.
[11] K. Mullane,et al. Reversal of accelerated neutrophil apoptosis and restoration of respiratory burst activity with r-metHuG-CSF (Filgrastim therapy in patients with AIDS. , 1999, AIDS.
[12] V. Calvez,et al. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease , 1998, The Lancet.
[13] I. Schedel,et al. Highly active antiretroviral therapy , 1998, The Lancet.
[14] G. Pantaleo. Immunology of HIV infection. , 1997, Research in immunology.
[15] K. Mullane,et al. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. , 1996, The Journal of clinical investigation.
[16] S. Ben‐Sasson,et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.
[17] L. Boxer,et al. Polymorphonuclear leukocyte function. , 1985, Hospital practice.
[18] H. Hill,et al. Polymorphonuclear Leukocyte Function in HIV , 1996 .